|
| |
| | 60326 | | 27.08.2010 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Votrient 200 mg | Filmtabletten | Coated tablets (Pazopanibum 200 mg) | L01XE11 | CI | 02 | Votrient 400 mg | Filmtabletten | Coated tablets (Pazopanibum 400 mg) | L01XE11 | CI |
|
|
|